The purpose of this study was to determine how a new self-report outcome measure of communicative participation, the Communicative Participation Item Bank (CPIB), related to disease- and discipline-specific quality of life (QOL) outcomes in a head and neck cancer (HNC) population.
Methods:
One hundred ninety-five individuals treated for HNC completed the CPIB, the University of Washington Quality of Life questionnaire (UW-QOL), and the Voice Handicap Index–10 (VHI-10).
Results:
Results revealed moderate QOL scores across the UW-QOL (mean scores: global QOL = 66; physical subscale = 70; social-emotional subscale = 73) and VHI-10 (mean = 16). Correlations between the CPIB and the UW-QOL scores were statistically significant (P < .001) but relatively weak (r = .37–.38). As hypothesized, a stronger correlation was found between the CPIB and the VHI-10 (r = −0.79; P < .001).
Conclusion:
Clinicians may consider adopting the CPIB to complement existing tools in assessing communication outcomes after HNC.
KarnellLHFunkGFHoffmanHT. Assessing head and neck cancer patient outcome domains. Head Neck. 2000;22(1):6-11.
2.
BjordalKFrengAThorvikJKaasaS. Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Eur J Cancer B Oral Oncol. 1995;31B(4):235-241.
3.
BloodG. Development and assessment of a scale addressing communication needs of patients with laryngectomies. Am J Speech Lang Path. 1993;2:82-87.
4.
Op de CoulBMAckerstaffAHvan AsCJ. Quality of life assessment in laryngectomized individuals: do we need additions to standard questionnaires in specific clinical research projects?Clin Otolaryngol. 2005;30(2):169-175.
5.
RinkelRNVerdonck-de LeeuwIMvan ReijEJAaaronsonNKLeemansCR. Speech handicap index in patients with oral and pharyngeal cancer: better understanding of patients’ complaints. Head Neck. 2008;30(7):868-874.
6.
EadieTLYorkstonKMKlasnerER. Measuring communicative participation: a review of self-report instruments in speech-language pathology. Am J Speech Lang Pathol. 2006;15:307-320.
7.
FunkGFKarnellLHChristensenAJ. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012;138(2):123-133.
8.
FrostMHReeveBBLiepaAMStaufferJWHaysRD, the Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. What is sufficient evidence for the reliability and validity of patient-reported outcome measures?Value Health. 2007;10(S2):S94–S105.
9.
BaylorCRYorkstonKMEadieTLMillerRMAmtmannD. Developing the Communicative Participation Item Bank: Rasch analysis results from a spasmodic dysphonia sample. J Speech Lang Hear Res. 2009;52:1302-1320.
10.
BaylorCRYorkstonKMEadieTLKimJChungHAmtmannD. The Communicative Participation Item Bank (CPIB): item bank calibration and development of a disorder-generic short form. J Speech Lang Hear Res. 2013;56:1190-1208.
11.
BaylorCRBurnsMEadieTLBrittonDYorkstonKM. A qualitative study of interference with communicative participation across communication disorders in adults. Am J Speech Lang Pathol. 2011;20:269-287.
12.
FranicDMBramlettREBotheAC. Psychometric evaluation of disease specific quality of life instruments in voice disorders. J Voice. 2005;19(2):300-315.
13.
CampbellBHMarbellaALaydePM. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope. 2000;110(6):895-906.
14.
HaysRDMoralesLSReiseSP. Item response theory and health outcomes measurement in the 21st century. Med Care. 2000;38(9):SII28-SII42.
15.
HassanSJWeymullerEAJr. Assessment of quality of life in head and neck cancer patients. Head Neck. 1993;15(6):485-496.
16.
RogersSNGwanneSLoweDHumphrisGYuehBWeymullerEAJr. The addition of mood and anxiety domains to the University of Washington Quality of Life Scale. Head Neck. 2002;24(6):521-529.
17.
RogersSNLoweDYuehBWeymullerEAJr. The physical function and social-emotional function subscales of the University of Washington Quality of Life Questionnaire. Arch Otolaryngol Head Neck Surg. 2010;136(4):352-357.
18.
RosenCALeeASOsborneJZulloTMurryT. Development and validation of the Voice Handicap Index-10. Laryngoscope. 2004;114(9):1549-1556.
19.
EvansECardingPDrinnanM. The Voice Handicap Index with post-laryngectomy male voices. Int J Lang Commun Disord. 2009;44(5):575-586.
20.
SamejimaF. Estimation of Latent Ability Using a Response Pattern of Graded Scores. Rockville, MD: Psychometric Society; 1969. Psychometrika Monograph No. 17.
El-DeiryMWFutranNDMcDowellJAWeymullerEAJrYuehB. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg. 2009;135(4):380-384.
23.
OridateNHommaASuzukiS. Voice-related quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2009;135(4):363-368.
24.
ThomasLJonesTMTandonSCardingPLoweDRogersS. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain. Clin Otolaryngol. 2009;23:34-42.
25.
TschiesnerURogersSNHarreusUBerghausACiezaA. Content comparison of quality of life questionnaires used in head and neck cancer based on the International Classification of Functioning, Disability and Health: a systematic review. Eur Arch Otorhinolaryngol. 2008;265(6):627-637.
26.
Van der MeiSJDijkersMPJMHeerkensYF. Participation as an outcome measure in psychosocial oncology: content of cancer-specific health-related quality of life instruments. Qual Lif Res. 2011;20:1617-1627.
27.
TschiesnerULinseisenEBaumannS. Assessment of functioning in patients with head and neck cancer according to the International Classification of Functioning, Disability and Health (ICF): a multicenter study. Laryngoscope. 2009;119(5):915-923.
28.
TschiesnerURogersSDietzAYuehBCiezaA. Development of ICF core sets for head and neck cancer. Head Neck. 2010;32(2):210-220.
29.
BjordalKHammerlidEAhlner-ElmqvistM. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999;17(3):1008-1019.
30.
RingashJO’SullivanBBezjakARedelmeierDA. Interpreting clinically significant changes in patient-reported outcomes. Cancer. 2007;110(1):196-202.
